Stocks to Watch: Contineum, Gap Inc., Geospace Technologies

Dow Jones
2025/11/21
 

By Katherine Hamilton

 

Contineum Therapeutics said its drug designed to treat multiple sclerosis didn't meet its trial endpoints. The stock fell 12%, to $10.75, in after-hours trading Thursday.

Gap Inc. raised its fiscal-year sales outlook after its three main brands logged same-store sales growth. Shares advanced 4.8%, to $24.16, after the bell.

Geospace Technologies said oil volatility and less offshore exploration resulted in an 11% drop in quarterly sales. The stock declined 11%, to $15.35.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

November 20, 2025 18:31 ET (23:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10